Michaelson Capital Partners

Renovare Environmental Inc is a technology services company that specializes in innovative waste management solutions for businesses and municipalities. The company aims to enhance environmental outcomes by offering cost-effective options for both on-site and off-site biological treatment of waste. Through its subsidiaries, BioHiTech America and BioHiTech Europe, Renovare delivers advanced products and services to minimize food waste and optimize disposal processes. Its pioneering on-site aerobic digestion technology integrates waste disposal equipment with cloud-based analytics, providing transparency into waste generation through Machine-to-Machine technology. This combination of technological innovation and data analytics supports organizations in their pursuit of ecological sustainability and contributes to a future with zero waste.

Tecogen is a manufacturer based in Waltham, Massachusetts, specializing in natural-gas-fueled, engine-driven combined heat and power products. Founded in 2000, the company focuses on creating ultra-efficient systems that reduce energy costs, lower greenhouse gas emissions, and help alleviate congestion on the national power grid. Its primary offerings include cogeneration modules that generate both electricity and heat, as well as chillers for air conditioning that can also provide free hot water. Tecogen operates through three main business segments: Products, which involves the design and manufacture of industrial and commercial cogeneration systems; Services, which includes operations, maintenance, and installation services under long-term contracts; and Energy Production, which sells electricity, heat, hot water, and cooling to customers through long-term energy sales agreements.

Entelos is a leading provider of predictive biosimulation technologies aimed at enhancing drug discovery and development. With over 15 years of experience, the company specializes in advanced biosimulation capabilities that improve the efficiency of research and development processes while increasing the likelihood of clinical success. Entelos offers a range of solutions, including mechanism-based mathematical models, virtual patients and populations, and biosimulation software. These tools provide in-depth systems biology data and predictive analyses that help organizations in the pharmaceutical, healthcare, nutrition, and consumer markets to develop safer and more effective drugs, foods, and products. By leveraging its expertise in biosimulation, Entelos significantly reduces the risk, time, and cost associated with product development.